Immunoreactive GPIIb-IIIa fragment, human leukocyte antigen class II restriction, T-cell helper activity inducing anti–GPIIb-IIIa antibody production, and cytokine profiles in GPIIb-IIIa–reactive CD4+ T-cell lines generated from patients with immune thrombocytopenic purpura
Line . | Donor . | Immunoreactive fragment . | HLA class II restriction . | Anti-GPIIb-IIIa antibody in culture (OD450)3-150 . | Cytokine level in culture (pg/mL)3-151 . | ||||
---|---|---|---|---|---|---|---|---|---|
With immunoreactive fragment . | With GST . | ||||||||
No treatment . | +Platelets3-152 . | IFN-γ . | IL-4 . | IL-6 . | |||||
FS4 | ITP8 | IIbα18-259 | HLA-DR | 0.267 | 0.055 | 0.029 | 256 | < 1 | 360 |
SiM4 | ITP14 | IIbα18-259 | HLA-DR | 0.351 | 0.101 | 0.048 | 456 | 9 | 296 |
SuM7 | ITP25 | IIbα566-841 | HLA-DR | 0.042 | 0.039 | 0.011 | 780 | 76 | 18 |
WY3 | ITP10 | IIIa22-262 | HLA-DR | 0.422 | 0.084 | 0.096 | NT | NT | NT |
WY5 | ITP10 | IIIa22-262 | HLA-DR | NT | NT | NT | NT | NT | NT |
WY9 | ITP10 | IIIa22-262 | HLA-DR, -DP | 0.567 | 0.109 | 0.124 | 280 | 86 | 567 |
NE4 | ITP24 | IIIa22-262 | HLA-DR | 0.196 | NT | 0.014 | 892 | 16 | 117 |
SuM8 | ITP25 | IIIa22-262 | HLA-DR | 0.397 | 0.051 | 0.017 | 667 | 67 | 396 |
Line . | Donor . | Immunoreactive fragment . | HLA class II restriction . | Anti-GPIIb-IIIa antibody in culture (OD450)3-150 . | Cytokine level in culture (pg/mL)3-151 . | ||||
---|---|---|---|---|---|---|---|---|---|
With immunoreactive fragment . | With GST . | ||||||||
No treatment . | +Platelets3-152 . | IFN-γ . | IL-4 . | IL-6 . | |||||
FS4 | ITP8 | IIbα18-259 | HLA-DR | 0.267 | 0.055 | 0.029 | 256 | < 1 | 360 |
SiM4 | ITP14 | IIbα18-259 | HLA-DR | 0.351 | 0.101 | 0.048 | 456 | 9 | 296 |
SuM7 | ITP25 | IIbα566-841 | HLA-DR | 0.042 | 0.039 | 0.011 | 780 | 76 | 18 |
WY3 | ITP10 | IIIa22-262 | HLA-DR | 0.422 | 0.084 | 0.096 | NT | NT | NT |
WY5 | ITP10 | IIIa22-262 | HLA-DR | NT | NT | NT | NT | NT | NT |
WY9 | ITP10 | IIIa22-262 | HLA-DR, -DP | 0.567 | 0.109 | 0.124 | 280 | 86 | 567 |
NE4 | ITP24 | IIIa22-262 | HLA-DR | 0.196 | NT | 0.014 | 892 | 16 | 117 |
SuM8 | ITP25 | IIIa22-262 | HLA-DR | 0.397 | 0.051 | 0.017 | 667 | 67 | 396 |
See Table 1 for abbreviations.
T-cell lines were cultured with autologous peripheral blood B cells in the presence of the immunoreactive GPIIb-IIIa fragment or GST for 10 days, and anti–GPIIb-IIIa antibody levels in culture supernatants were measured by ELISA.
T-cell lines were stimulated with phytohemagglutinin and anti-CD3 mAb for 3 days, and cytokine levels in culture supernatants were measured by ELISA.
Culture supernatants were incubated with normal platelets before being applied to anti–GPIIb-IIIa antibody ELISA.